Summary
Definition
History and exam
Key diagnostic factors
- amenorrhea or oligomenorrhea
- infertility
- galactorrhea
- loss of sexual desire (libido)
- erectile dysfunction
- visual deterioration (e.g., temporal hemianopia)
Risk factors
- genetic predisposition (e.g., presence of mutation resulting in multiple endocrine neoplasia-1[MEN-1], familial isolated pituitary adenoma [FIPA])
- estrogen therapy
- female gender, 20 to 50 years of age
- male gender, 30 to 60 years of age
Diagnostic investigations
1st investigations to order
- serum prolactin
- pituitary MRI
- computerized visual-field examination
Treatment algorithm
Contributors
Authors VIEW ALL
Clinical Senior Lecturer in Endocrinology
Imperial Centre for Endocrinology
Department of Medicine
Imperial College London
London
UK
Disclosures
NM declares that she has no competing interests.
Dr Niamh Martin would like to gratefully acknowledge Dr Ilan Shimon, the previous contributor to this monograph. IS receives consultancy and lecturing fees from Pfizer, Israel. IS is an author of a number of references cited in this monograph.
Peer reviewers VIEW ALL
Professor
Division of Endocrinology
Northwestern University Feinberg School of Medicine
Chicago
IL
Disclosures
MM is an author of a number of references cited in this monograph.
Use of this content is subject to our disclaimer